Vogt P, Raab R, Ringe B, Pichlmayr R
Department of Surgery, Hannover Medical School, Federal Republic of Germany.
World J Surg. 1991 Jan-Feb;15(1):62-7. doi: 10.1007/BF01658964.
Whereas resection for metachronous liver metastases from colorectal cancer is considered to be a potentially curative approach, little is known about the prognosis after resection of synchronous liver metastases. In the past, these patients usually underwent only palliative therapy. Therefore, we have analyzed the data of 36 patients who underwent curative hepatic resection of synchronous liver metastases from colorectal carcinomas from 1977 to 1987 at the Department of Surgery, Hannover Medical School. In 19 patients, liver resection was combined with colonic resection; in the other 17 patients, hepatic resection was performed after a median interval of 2 months following resection of the primary tumor. No operative mortality was observed in either of the approaches. The median survival time was 28 months for all patients with a median recurrence-free interval of 13.5 months. Overall 5-year survival probability for all patients was 20%. There were no significant differences observed between immediate or delayed liver resection (median survival 18 months versus 31 months). Survival rates were not different after resection of solitary versus multiple liver metastases (26 versus 28 months). Twenty-one of the 36 patients had a recurrence of their liver metastases. In 7 of them, curative liver resection could be performed again. These 7 patients had a significantly improved survival (p less than 0.05) compared to the residual 14 patients. It is concluded that patients with synchronous liver metastases from colorectal cancer may profit from resection of the primary tumor and liver metastases. Timing of liver resection--immediate versus delayed--obviously has no impact on survival rates.
虽然结直肠癌异时性肝转移的切除术被认为是一种潜在的治愈方法,但对于同时性肝转移切除术后的预后了解甚少。过去,这些患者通常仅接受姑息治疗。因此,我们分析了1977年至1987年在汉诺威医学院外科接受结直肠癌同时性肝转移根治性肝切除术的36例患者的数据。19例患者肝切除与结肠切除联合进行;另外17例患者在原发肿瘤切除后中位间隔2个月后进行肝切除。两种方法均未观察到手术死亡。所有患者的中位生存时间为28个月,中位无复发生存期为13.5个月。所有患者的总体5年生存概率为20%。即刻或延迟肝切除之间未观察到显著差异(中位生存时间分别为18个月和31个月);孤立性与多发性肝转移切除后的生存率无差异(分别为26个月和28个月)。36例患者中有21例出现肝转移复发。其中7例患者可再次进行根治性肝切除。与其余14例患者相比,这7例患者的生存有显著改善(p<0.05)。结论是,结直肠癌同时性肝转移患者可能从原发肿瘤和肝转移的切除中获益。肝切除的时机——即刻与延迟——显然对生存率没有影响。